Product Details
Mometasone Furoate and Formoterol Fumarate Inhaler is a fixed-dose combination therapy used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients requiring both inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA).
- Mometasone Furoate: A potent corticosteroid that reduces inflammation, swelling and mucus in the airways
- Formoterol Fumarate: A rapid-onset LABA that provides sustained bronchodilation for up to 12 hours
This combination helps in improving pulmonary function, reducing asthma symptoms and minimizing exacerbation risks, especially in moderate to severe cases.
Indications
- Indicated for maintenance treatment of asthma in patients aged 12 years and older
- Suitable for moderate to severe asthma requiring dual therapy
- Indicated for maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema
- Helps reduce the need for rescue medications and prevents disease progression